What is BARK's health score?

Bark, Inc. (BARK) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BARK's estimated fair value?

Based on our 5-year discounted cash flow model, Bark, Inc.'s estimated fair value is $12.44 per share, representing a 28.7% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BARK undervalued or overvalued?

Our model currently rates BARK as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

Bark, Inc. (BARK)

Consumer Cyclical Undervalued low weak

$9.66

Updated: 2026-07-16

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

18 Stressed

Relative Value

40 Weak

Capital Allocation

75 Strong

Risk Management

70 Healthy

Est. Fair Value $12.44

DCF Upside +28.7%

Sector Rank #625 of 6147

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Industry Related Stocks

Alpine Auto Brokers Inc. (ALTB) Bath & Body Works, Inc. (BBWI) Boqii Holding Ltd (BQ) 1 800 FLOWERS COM INC (FLWS) High Tide Inc. (HITI) JD.com, Inc. (JD)

See all Consumer Cyclical stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.